We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Targa Resources
TRGP
$56.8B
| $12M | 0.03% |
199,673
+23,024
| +13% | +$1.34M |
|
577
Teradyne
TER
$50B
| $12M | 0.03% |
384,540
+29,093
| +8% | +$832K |
|
|
ULTI
578
DELISTED
Ultimate Software Group Inc
ULTI
| $11.9M | 0.03% |
61,216
+2,064
| +3% | +$402K |
|
579
Seagate
STX
$174B
| $11.9M | 0.03% |
259,210
+18,509
| +8% | +$822K |
|
580
CF Industries
CF
$19.6B
| $11.9M | 0.03% |
405,130
+14,686
| +4% | +$479K |
|
581
Service Corp International
SCI
$11.8B
| $11.8M | 0.03% |
381,955
+7,410
| +2% | +$223K |
|
|
PNRA
582
DELISTED
Panera Bread Co
PNRA
| $11.8M | 0.03% |
44,927
+1,731
| +4% | +$393K |
|
583
Old Dominion Freight Line
ODFL
$46.3B
| $11.7M | 0.03% |
409,431
+25,659
| +7% | +$759K |
|
584
Douglas Emmett
DEI
$2.05B
| $11.7M | 0.03% |
303,666
+20,273
| +7% | +$778K |
|
|
PACW
585
DELISTED
PacWest Bancorp
PACW
| $11.7M | 0.03% |
218,919
+8,418
| +4% | +$461K |
|
586
Workday
WDAY
$41.5B
| $11.6M | 0.03% |
139,293
+3,891
| +3% | +$323K |
|
|
QVCGA
587
DELISTED
QVC Group Inc Series A
QVCGA
| $11.6M | 0.03% |
11,889
+603
| +5% | +$567K |
|
|
ABMD
588
DELISTED
Abiomed Inc
ABMD
| $11.5M | 0.03% |
92,070
+2,706
| +3% | +$314K |
|
589
United Therapeutics
UTHR
$26.1B
| $11.5M | 0.03% |
84,852
+4,088
| +5% | +$619K |
|
590
Bank OZK
OZK
$5.63B
| $11.5M | 0.03% |
220,535
-3,969
| -2% | -$214K |
|
|
TWTR
591
DELISTED
Twitter, Inc.
TWTR
| $11.5M | 0.03% |
767,008
+53,544
| +8% | +$869K |
|
592
Tyler Technologies
TYL
$13.7B
| $11.5M | 0.03% |
74,133
+2,279
| +3% | +$347K |
|
593
PTC
PTC
$15.3B
| $11.4M | 0.03% |
217,528
+8,250
| +4% | +$436K |
|
594
Thor Industries
THO
$4.06B
| $11.4M | 0.03% |
118,874
-920
| -0.8% | -$95.5K |
|
595
Williams-Sonoma
WSM
$27.5B
| $11.4M | 0.03% |
425,686
+26,248
| +7% | +$640K |
|
596
MSC Industrial Direct
MSM
$6.76B
| $11.4M | 0.03% |
110,645
-4,094
| -4% | -$415K |
|
597
Graco
GGG
$13.2B
| $11.3M | 0.03% |
361,362
+10,830
| +3% | +$327K |
|
598
Brown & Brown
BRO
$25.1B
| $11.3M | 0.03% |
539,998
+105,896
| +24% | +$2.29M |
|
599
Take-Two Interactive
TTWO
$46.1B
| $11.2M | 0.03% |
189,777
+65,239
| +52% | +$3.64M |
|
|
EV
600
DELISTED
Eaton Vance Corp.
EV
| $11.2M | 0.03% |
249,543
+12,499
| +5% | +$554K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.